Skip to Main Content

Paper Details

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts.
Cancers (Basel)
6
2022
CCNU, DNA mismatch repair genes, GBM, Glioblastoma, IDH-wildtype, IDH-wildtype glioblastoma patient-derived xenografts, PDX, PDX models, Patient, diffusely infiltrating gliomas, glioblastoma, glioma, gliomas, lomustine, nitrosourea, patient, patients, post-temozolomide PDX, recurrent, temozolomide, tumor, tumors
Author NameAffiliation
Kathleen McCortneyNorthwestern University Feinberg School of Medicine
Shi-Yuan ChengRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Shi-Yuan ChengLou and Jean Malnati Brain Tumor Institute of Northwestern Medicine
Shi-Yuan ChengNorthwestern University Feinberg School of Medicine
Jann N SarkariaMayo Clinic
Roger StuppRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Roger StuppLou and Jean Malnati Brain Tumor Institute of Northwestern Medicine
Roger StuppNorthwestern University Feinberg School of Medicine
Amy B HeimbergerRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Amy B HeimbergerLou and Jean Malnati Brain Tumor Institute of Northwestern Medicine
Amy B HeimbergerNorthwestern University Feinberg School of Medicine
Charles D JamesRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Charles D JamesLou and Jean Malnati Brain Tumor Institute of Northwestern Medicine
Charles D JamesNorthwestern University Feinberg School of Medicine
Craig HorbinskiNorthwestern University Feinberg School of Medicine
Craig HorbinskiRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Craig HorbinskiLou and Jean Malnati Brain Tumor Institute of Northwestern Medicine
Craig HorbinskiNorthwestern University Feinberg School of Medicine
  • 1 - 18

Datasets

Release 1.2